Proton Radiotherapy Plus Tremelimumab/Durvalumab for BCLC Stage B and C HCC
Clinical trial NCT06999694 · RECRUITING
Trial details
- NCT number
- NCT06999694
- Sponsor
- Chang Gung Memorial Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-22
- Primary completion
- 2030-05-31
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.